Related Experiment Video
Updated: Feb 6, 2026

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
Published on: April 10, 2018
Long non-coding RNA CASC2 in solid tumors: A meta-analysis
Chaojie Liang1, Jinghong Zhang1, Hua Ge1
1Department of General Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
Background And Aim:
Recently, several studies have reported that the long non-coding RNA cancer susceptibility 2 (CASC2) is downregulated in human solid tumors. However, as the sample size in those studies was limited, the role of CASC2 in cancer remains unknown. Accordingly, we conducted this meta-analysis to explore the role of CASC2 in solid tumors.
Methods:
We systematically searched the PubMed, Medline, Cochrane Library, Web of Science, EMBASE, Ovid, Chinese CNKI, and Chinese WanFang databases. Pooled odds ratios (ORs) and hazard ratios (HRs) with 95% confidence interval (CI) were used to evaluate the relation between CASC2 and the clinicopathological characteristics and prognosis of patients with cancer. Additionally, we also use The Cancer Genome Atlas (TCGA) dataset to analyze CASC2 expression.
Results:
A total of 15 studies with 1158 patients were included in this meta-analysis. The pooled results demonstrated that the expression of CASC2 was related to tumor size (large vs. small: OR = 0.40, 95% CI = [0.30, 0.52]), differentiation (low vs. high+ moderate: OR = 0.42, 95% CI = [0.29, 0.62]) and TNM stage (I + II vs. III + IV: OR = 2.74, 95% CI = [2.08, 3.60]), but not to age, gender and differentiation. High CASC2 expression indicated better overall survival (OS) (HR = 0.41, 95% CI = [0.32, 0.50]) and disease-free survival (DFS) (HR = 0.48, 95% CI = [0.26, 0.66]). Additionally, similar results were obtained through analysis of the TCGA data set. Moreover, it was determined that CASC2 could be an independent predictive factor for OS (HR = 0.38, 95% CI = [0.22, 0.54]) in patients with cancer.
Conclusion:
This analysis revealed that low CASC2 expression was correlated with advanced clinicopathological characteristics of cancer tumors, and CASC2 may thus be a potential prognostic biomarker in human cancer. However, more studies are needed to further corroborate these findings.
Insights
This meta-analysis found that low expression of cancer susceptibility 2 (CASC2) is linked to advanced cancer characteristics. Higher CASC2 levels correlate with better patient survival, suggesting CASC2 as a potential cancer biomarker.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long non-coding RNA cancer susceptibility 2 (CASC2) is frequently downregulated in human solid tumors.
- Previous studies had limited sample sizes, leaving the role of CASC2 in cancer unclear.
Purpose of the Study:
- To conduct a meta-analysis to explore the role of CASC2 in solid tumors.
- To investigate the association between CASC2 expression and clinicopathological characteristics and prognosis of cancer patients.
Main Methods:
- Systematic literature search across multiple databases (PubMed, Medline, Web of Science, EMBASE, etc.).
- Meta-analysis of 15 studies involving 1158 patients.
- Analysis of The Cancer Genome Atlas (TCGA) dataset for CASC2 expression.
Main Results:
- Low CASC2 expression correlated with larger tumor size, lower differentiation, and advanced TNM stage.
- High CASC2 expression was associated with improved overall survival (OS) and disease-free survival (DFS).
- CASC2 was identified as an independent predictive factor for OS.
Conclusions:
- Reduced CASC2 expression is linked to unfavorable clinicopathological features in human cancers.
- CASC2 shows potential as a prognostic biomarker for cancer.
- Further research is recommended to validate these findings.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Metallic Solids
All metallic solids exhibit high thermal and electrical conductivity, metallic luster, and malleability....
Structures of Solids
RNA Splicing
Network Covalent Solids
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...

